磁外科:美国首例新型装置临床应用经验
患者平均年龄49.0岁,平均BMI 27.6 kg/m2,平均手术时间64.4分钟,无围术期并发症。作者认为该系统安全可行,可能减少穿刺器数量,但需更多研究确定其他普外科适用性。
要点
- Levita磁外科系统获FDA批准用于BMI 21–34 kg/m2的腹腔镜胆囊切除术患者。
- 7例(70.0%)手术当日出院,3例(30.0%)术后第1天出院。
核心结论
- Levita™磁外科系统在腹腔镜胆囊切除术中安全可行。
- 常规使用可能减少腹腔镜穿刺器总数,从而减少组织创伤并改善美容效果。
- 尚需更多研究确定该系统在其他普外科病例中的适用性和效用。
研究设计与样本
- 收集基线特征、手术时间和围术期细节。
主要发现
- 患者平均年龄49.0岁,平均BMI 27.6 kg/m2。
- 平均手术时间64.4分钟,无围术期并发症。
- 7例(70.0%)手术当日出院,3例(30.0%)术后第1天出院。
- 术者报告磁抓钳易于使用,并提供足够的组织牵拉和暴露。
关键数值与推荐
- Levita™磁外科系统获FDA批准用于BMI 21–34 kg/m2的腹腔镜胆囊切除术患者。
- 系统包括可展开的磁抓钳和体外磁体,用于在腹腔内操纵抓钳。
临床怎么用
- 对于符合BMI 21–34 kg/m2的腹腔镜胆囊切除术患者,可考虑使用Levita™磁外科系统辅助牵拉。
局限性
- 仅纳入择期手术且BMI 21–34 kg/m2的患者。
- 随访和评价指标有限,缺乏对照。
- 其他普外科病例的适用性尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Magnet-assisted surgery is a new platform within minimally invasive surgery. The Levita™ Magnetic Surgical System, the first magnetic surgical system to receive Food and Drug Administration (FDA) approval, includes a deployable, magnetic grasper and an external magnet that is used to manipulate the grasper within the peritoneal cavity. This system is currently approved for patients undergoing laparoscopic cholecystectomy with a body mass index (BMI) between 21 and 34 kg/m2. Herein, we detail the first United States experience with the Levita™ Magnetic Surgical System during laparoscopic cholecystectomy. METHODS: The Levita™ Magnetic Surgical System was used on consecutive patients undergoing laparoscopic cholecystectomy at our institution from June 2016 through November 2016. Only patients undergoing elective surgery and those with a body mass index (BMI) between 21 and 34 kg/m2 were included. Baseline patient characteristics, operative time, and perioperative details were collected. RESULTS: A total of ten patients underwent laparoscopic cholecystectomy with the Levita™ Magnetic Surgical System during the defined study period. The mean age at the time of surgery was 49.0 years and the average BMI of the cohort was 27.6 kg/m2. The average operative time was 64.4 min. There were no perioperative complications. Seven (70.0%) patients were discharged to home on the day of surgery, while the remaining three (30.0%) patients were discharged to home on postoperative day number one. Surgeons reported that the magnetic grasper was easy to use and provided adequate tissue retraction and exposure. CONCLUSIONS: The Levita™ Magnetic Surgical System is safe and feasible to use in patients undergoing laparoscopic cholecystectomy. Routine use of this system may facilitate a reduction in the total number of laparoscopic trocars used, leading to less tissue trauma and improved cosmesis. Additional studies are needed to determine the applicability and utility of this system for other general surgery cases.
引用
- Haskins IN, Strong AT, Allemang MT, et al. Magnetic surgery: first U.S. experience with a novel device. Surg Endosc. 2017. PMID: 28733750. doi:10.1007/s00464-017-5762-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。